Maximizing a smooth supply chain by enlightening regulatory requirements and encouraging cross-department cooperation
The 9th Annual Pharma Packaging and Labeling East Coast is back in 2017 on the 22rd-23th February for what promises to be a fantastic event. This event will ensure you will benefit from a wealth of topics within commercial packaging and labeling.
Over two days, you will be learning and exploring with peers in the pharma, biotech and medical device field to gain actionable strategies to improve your day-to-day operations and insights into US and non-US markets to maximize cost efficiency.
At the 2017 event, we will be examining the operational challenges with serialization from various perspectives – labeling, packaging, serialization and supply chain to optimize the process and ensure a smooth orchestra of multiple functional departments.
Please take a look around our website and reserve your entry pass before it is too late to enjoy this great learning and networking opportunity!
The pharmaceutical industry is increasingly falling victim to counterfeit medicines and theft throughout the supply chain. Serialization can be implemented to prevent this.
As Pennsylvania’s largest city, Philadelphia is not only offers a range of food and drink,merging American and Italian cuisines, but also presents a plethora of culture, having been founded in 1682.
The hottest topic in pharma for last 5 years – serialization finally seems to come to the end as the pharma companies are fully equipped with preparation for the deadline in 2017.
According to Interpol’s flagship pharmaceutical investigation, Operation Pangea, the size of fake and illicit pills was seized 20.7 million in 2015. Today it is estimated that counterfeit versions of more than 800 pharmaceutical drugs are circulating in markets globally.
The 9th Pharma Packaging and Labeling is coming back to Philadelphia from 22 to 23 February.
The Pharma Packaging and Labeling East Coast conference attracts a diverse audience from big, medium and small pharma and biotechs from across the United States.